Moderna, Pfizer and AstraZeneca have started phase 3 trials, while government officials have approved Operation Warp Speed – in the US. The Virus is Spreading Throughout the Winter, Vaccines are More Important than EverĪccording to the World Health Organization, as of November 6th 2020, over 52 million people worldwide are infected with coronavirus, of which about 1.2 million are said to have died with the disease.Ī team of New York Times journalists has closely followed every single COVID-19 vaccine trialtaking place worldwide, and more than 100 vaccines are in development. He said he also expected the other dose of 700 million to be available by April 2021, but he said it was a goal they would struggle to meet. He added that even if the vaccine is approved by the end of the year, only about 50 million doses would be available, and that will not be enough to provide half the population with the vaccine by 2020’s end. “If the vaccine proves safe and effective, approval before the end of the year is looking more likely than a few weeks ago”, he said. Later in the hearing, Bancel testified that he had predicted that 700 million doses of the coronavirus vaccine would be available by the end of March or early April. The pharmaceutical company told the Financial Times that it is seeking approval for the vaccine from the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).Īt a health conference on Wednesday, Bancel said it would not be able to seek FDA approval for its new vaccine until late January at the earliest. Moderna chief executive Stephane Bancel said on Wednesday that his company’s new vaccine against coronavirus would not be ready for widespread public distribution until spring next year, according to reports.
0 kommentar(er)
